Cambridge, United Kingdom

Claire Louise Dobson

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 239(Granted Patents)


Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: The Innovative Contributions of Claire Louise Dobson in Biomedicine

Introduction

Claire Louise Dobson is a prominent inventor based in Cambridge, GB, recognized for her outstanding contributions to the field of biomedicine. With an impressive portfolio of 15 patents, she has made significant strides in developing novel therapeutic proteins and antibodies, enhancing the fight against various diseases, including cancer.

Latest Patents

Among her latest innovations is the patent for bispecific binding proteins and their applications. This disclosure presents proteins that bind two epitopes, showcasing their bivalent nature for effective binding. It not only includes antibodies that bind to target proteins but also comprises compositions involving such proteins, along with nucleic acid molecules encoding them. Moreover, this invention provides methods for inducing immune responses and treating or preventing cancer by administering these innovative proteins and compositions.

Another notable patent involves antibodies directed against GDF-15. This invention is centered on human GDF-15-binding antibodies and their antigen-binding fragments. These antibodies can be utilized to detect human GDF-15 and have implications in treating conditions like cancer and cachexia, which is often associated with an over-expression of GDF-15.

Career Highlights

Claire has built a remarkable career collaborating with reputable organizations such as MedImmune Limited and Human Genome Sciences, Inc., where her expertise in biomedicine was pivotal in driving innovation. Her work in these institutions reflects her commitment to advancing biomedical research and therapeutic development.

Collaborations

Throughout her career, Claire has collaborated with noted professionals in her field, such as Per-Olof Fredrik Eriksson and Karin Von Wachenfeldt. These partnerships have further enriched her research and allowed for the exchange of knowledge and innovative ideas, fostering advancements in their collective endeavors.

Conclusion

Claire Louise Dobson's innovative spirit and dedication to her research have positioned her as a leading figure in the realm of biomedical inventions. Her patents represent significant advancements in the treatment of critical health issues, particularly in cancer therapy. With her contributions, Claire continues to inspire future inventors and researchers pursuing excellence in innovation and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…